Skip to main content
. Author manuscript; available in PMC: 2022 May 24.
Published in final edited form as: JACC Cardiovasc Interv. 2021 May 24;14(10):1094–1105. doi: 10.1016/j.jcin.2021.03.049

Figure 2.

Figure 2

Competing risk cumulative incidence curves for (A) myocardial infarction, (B) stent thrombosis, (C) revascularization, and (D) bleeding stratified by high and low dual antiplatelet therapy (DAPT) score in noncancer patients after percutaneous coronary intervention (PCI) and group comparison by Gray’s test.